Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Salvage therapy for soft tissue sarcomas

A D Elias1

  • 1Department of Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115.

Seminars in Oncology
|August 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment Efficacy Score-continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours.

European journal of cancer (Oxford, England : 1990)·2013
Same author

High dose chemotherapy with stem cell rescue for breast cancer: current status and future directions.

Breast disease·2005
Same author

The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2002
Same author

A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer: sequential phase I/II studies.

Bone marrow transplantation·2001
Same author

A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.

Bone marrow transplantation·2001
Same journal

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

Seminars in oncology·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Seminars in oncology·2026
See all related articles

Effective sarcoma treatment requires accurate diagnosis, staging, and surgical assessment. Chemotherapy, including doxorubicin and ifosfamide combinations, offers palliative care for soft tissue sarcomas, but new agents are needed for metastatic disease.

Area of Science:

  • Oncology
  • Sarcoma Research
  • Connective Tissue Tumors

Background:

  • Sarcomas are rare and diverse tumors.
  • Effective initial treatment is crucial to avoid salvage therapies.
  • Management involves biopsy, staging, and surgical assessment.

Purpose of the Study:

  • To review current clinical management strategies for sarcomas.
  • To evaluate the efficacy of chemotherapy and biologic agents.
  • To identify needs for improved sarcoma therapies.

Main Methods:

  • Review of clinical management protocols for sarcomas.
  • Analysis of chemotherapy drug efficacy (doxorubicin, ifosfamide).
  • Assessment of combination chemotherapy regimens (CyADIC, MAI).

Related Experiment Videos

Main Results:

  • Surgery and radiotherapy are key for local control in resectable disease.
  • Pulmonary metastatectomy is indicated for isolated lung recurrence.
  • Doxorubicin and ifosfamide show >20% activity; combination regimens yield 40-57% response rates.
  • No survival advantage for combination chemotherapy in metastatic disease.
  • Biologic agents have limited efficacy as single agents; antiangiogenic therapy shows potential synergy.

Conclusions:

  • New chemotherapeutic agents and strategies to overcome drug resistance are essential.
  • Improved therapies are needed to enhance treatment efficacy for sarcoma patients.